Home » Topics » BioWorld Science

BioWorld Science
RSS

Bayer patents cytostatic conjugates with integrin alphavbeta3 ligands

June 3, 2020

Preliminary safety data reported from ILLUMINATE-206 study

June 3, 2020

MAP3K5 inhibitors discovered at Enanta Pharmaceuticals

June 3, 2020

FDA clears IND application for SNK-01 in combination with trastuzumab or cetuximab

June 3, 2020

Nimbus Artemis describes new ATP-citrate synthase inhibitors

June 3, 2020

Maximum tolerated dose identified with positive safety profile for CC-92480 in multiple myeloma

June 3, 2020

Trevena and Imperial College London collaborate to evaluate TRV-027 in patients with COVID-19

June 3, 2020

Danish Medical Agency approves CTA application for AP-1189 in nephrotic syndrome

June 3, 2020

Sarclisa approved in Europe for adults with relapsed and refractory multiple myeloma

June 3, 2020

Lilly initiates phase I study of LY-CoV555 for COVID-19

June 3, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...